Form 4: Waystar Holding Corp. Executive Eric L. (Ric) Sinclair III Reports Stock and Options Grants
SEC Form 4 Filing
Chief Business Officer Eric L. (Ric) Sinclair III reports the acquisition of restricted stock units and stock options in Waystar Holding Corp.
Summary
- Eric L. (Ric) Sinclair III, Chief Business Officer of Waystar Holding Corp., filed a Form 4 detailing changes in beneficial ownership.
- On June 10, 2024, Sinclair acquired 173,913 shares of Common Stock through a grant of restricted stock units (RSUs) at a price of $0.
- These RSUs vest in five substantially equal annual installments starting June 6, 2025, and each RSU represents the right to receive one share of common stock.
- Sinclair also holds stock options to purchase 72,600 shares at $37.20, granted on May 1, 2024, vesting in three equal annual installments commencing May 1, 2025.
- Additionally, Sinclair holds options to purchase 434,782 shares at $21.50, granted on June 6, 2024, vesting in five equal annual installments commencing June 6, 2025.
- The filing reflects a 0.605-for-1 reverse stock split that became effective on May 15, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports transactions related to executive compensation, which is a normal business practice. There are no explicit positive or negative implications.
Positives
- The grant of RSUs and stock options to a key executive like the Chief Business Officer can be seen as an incentive to drive company performance.
- The vesting schedules for the RSUs and stock options align the executive's interests with the long-term success of the company.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedules of the RSUs and stock options suggest a focus on long-term performance.
Industry Context
Executive compensation through stock options and RSUs is a common practice in the corporate world, particularly in publicly traded companies, to align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option and RSU grants are standard compensation practices for executives in publicly traded companies.
- Vesting schedules, typically ranging from three to five years, are designed to incentivize long-term commitment and performance.
- The specific amounts and terms of the grants would need to be compared to those of peer companies in the healthcare technology sector to assess their competitiveness.
Stakeholder Impact
- The grants of RSUs and stock options could potentially impact shareholder value depending on the future performance of the company.
- Employees may view the executive compensation package as a reflection of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Grant date of stock options to purchase 72,600 shares at $37.20, vesting in three equal annual installments commencing on this date in 2025. |
| 05/15/2024 | Effective date of the 0.605-for-1 reverse stock split. |
| 06/06/2024 | Grant date of stock options to purchase 434,782 shares at $21.50, vesting in five equal annual installments commencing on this date in 2025. |
| 06/10/2024 | Date of RSU grant for 173,913 shares, vesting in five equal annual installments commencing June 6, 2025. |
| 06/12/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.